Trial intelligence / Profile preview

Efficacy and safety study of Epoetin alfa in Thai patients under CAPD

TCTR20140128002Phase 4Recruiting

Sponsor
Apexcela
Start
Feb 2014
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of epoetin alfa in anaemia, sponsored by Apexcela. Started Feb 2014; status: recruiting.

02

Drugs

epoetin alfa
03

Conditions

anaemia

Beyond the preview

Go deeper on TCTR20140128002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20140128002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call